JP2024016237A5 - - Google Patents

Download PDF

Info

Publication number
JP2024016237A5
JP2024016237A5 JP2023192683A JP2023192683A JP2024016237A5 JP 2024016237 A5 JP2024016237 A5 JP 2024016237A5 JP 2023192683 A JP2023192683 A JP 2023192683A JP 2023192683 A JP2023192683 A JP 2023192683A JP 2024016237 A5 JP2024016237 A5 JP 2024016237A5
Authority
JP
Japan
Prior art keywords
inhibitor
dose
seq
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023192683A
Other languages
English (en)
Japanese (ja)
Other versions
JP7811933B2 (ja
JP2024016237A (ja
Filing date
Publication date
Priority claimed from PCT/US2018/045195 external-priority patent/WO2019028367A1/en
Priority claimed from JP2020505844A external-priority patent/JP7417515B2/ja
Application filed filed Critical
Publication of JP2024016237A publication Critical patent/JP2024016237A/ja
Publication of JP2024016237A5 publication Critical patent/JP2024016237A5/ja
Application granted granted Critical
Publication of JP7811933B2 publication Critical patent/JP7811933B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023192683A 2017-08-04 2023-11-13 活動性好酸球性食道炎を治療する方法 Active JP7811933B2 (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201762541242P 2017-08-04 2017-08-04
US62/541,242 2017-08-04
US201762561593P 2017-09-21 2017-09-21
US62/561,593 2017-09-21
EP18305252 2018-03-08
EP18305252.1 2018-03-08
PCT/US2018/045195 WO2019028367A1 (en) 2017-08-04 2018-08-03 METHODS OF TREATING ESOPHAGITIS WITH ACTIVE EOSINOPHILES
JP2020505844A JP7417515B2 (ja) 2017-08-04 2018-08-03 活動性好酸球性食道炎を治療する方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020505844A Division JP7417515B2 (ja) 2017-08-04 2018-08-03 活動性好酸球性食道炎を治療する方法

Publications (3)

Publication Number Publication Date
JP2024016237A JP2024016237A (ja) 2024-02-06
JP2024016237A5 true JP2024016237A5 (enExample) 2024-10-17
JP7811933B2 JP7811933B2 (ja) 2026-02-06

Family

ID=63113646

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020505844A Active JP7417515B2 (ja) 2017-08-04 2018-08-03 活動性好酸球性食道炎を治療する方法
JP2023192683A Active JP7811933B2 (ja) 2017-08-04 2023-11-13 活動性好酸球性食道炎を治療する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020505844A Active JP7417515B2 (ja) 2017-08-04 2018-08-03 活動性好酸球性食道炎を治療する方法

Country Status (9)

Country Link
EP (1) EP3661551A1 (enExample)
JP (2) JP7417515B2 (enExample)
KR (2) KR20240152980A (enExample)
CN (1) CN111032084A (enExample)
AU (2) AU2018311981B2 (enExample)
CA (1) CA3071528A1 (enExample)
IL (2) IL315556A (enExample)
MA (1) MA49744A (enExample)
MX (2) MX2020001305A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230015965A (ko) * 2020-05-22 2023-01-31 리제너론 파아마슈티컬스, 인크. Il-4r 억제제를 투여함에 의해 호산구성 식도염을 치료하기 위한 방법
GB202102277D0 (en) * 2021-02-18 2021-04-07 Nordic Bioscience As Immunoassay for detecting Eosinophilic Esophagitis
KR20250007616A (ko) * 2022-04-29 2025-01-14 아케소 바이오파마, 인크. 항-인간 il-4ra 항체 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI634900B (zh) * 2013-07-11 2018-09-11 再生元醫藥公司 藉由投與il-4r抑制劑治療嗜酸性食道炎的方法
BR112016008694A2 (pt) * 2013-10-23 2017-10-03 Genentech Inc Métodos de previsão da reação de pacientes com asma, de previsão da capacidade de reação de pacientes com asma, de identificação de pacientes com asma, de tratamento de pacientes portadores de asma e de tratamento de asma, uso de um kit e kit
CA2978026A1 (en) * 2015-03-11 2016-09-15 Glaxosmithkline Intellectual Property Development Limited Tslp binding proteins

Similar Documents

Publication Publication Date Title
JP2024016237A5 (enExample)
CN105392497B (zh) 以il-4r抑制剂治疗嗜酸性食管炎的方法
Kim et al. Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases
JP2015527364A5 (enExample)
RU2015109716A (ru) Способы лечения или предотвращения астмы посредством введения антагониста il-4r
JP2022169718A5 (enExample)
JP2022160685A5 (enExample)
JP2019531273A5 (enExample)
RU2016101632A (ru) Способы лечения полипоза носа путем введения антагониста il-4r
JP2018158934A (ja) 抗il−5抗体を投与するための方法
JP2017535547A5 (enExample)
JP2020500152A5 (enExample)
RU2019111921A (ru) Способы лечения тяжелого атопического дерматита путем введения ингибитора il-4r
JP2019529560A5 (enExample)
JP2021502349A5 (enExample)
KR20140061403A (ko) 항―il―13 항체를 이용하여 천식을 치료하기 위한 방법 및 조성물
JP2020502261A5 (enExample)
JPWO2019222055A5 (enExample)
JPWO2021237110A5 (enExample)
JP2025072440A5 (enExample)
JPWO2021026205A5 (enExample)
JP2020529434A5 (enExample)
JP2020073525A5 (enExample)
JPWO2021195530A5 (enExample)
HRP20191709T1 (hr) Postupci liječenja nosne polipoze davanjem antagonista il-4r